Sitagliptin for Prophylaxis of Acute Graft-versus-Host Disease.

Jaschke, Nikolai P; Link-Rachner, Cornelia S; Rachner, Tilman D

Jaschke, Nikolai P; Link-Rachner, Cornelia S; Rachner, Tilman D.

Affiliation

Jaschke NP; Technische Universität Dresden, Dresden, Germany tilman.rachner@uniklinikum-dresden.de.
Link-Rachner CS; Technische Universität Dresden, Dresden, Germany tilman.rachner@uniklinikum-dresden.de.
Rachner TD; Technische Universität Dresden, Dresden, Germany tilman.rachner@uniklinikum-dresden.de.

N Engl J Med ; 384(14): 1375, 2021 04 08.

Article in En | MEDLINE | ID: mdl-33826828

Subject(s)

Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Dipeptidyl Peptidase 4; Graft vs Host Disease/prevention & control; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Sitagliptin Phosphate/therapeutic use; Transplantation Conditioning

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: En Journal: N Engl J Med Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google